Busulfan News

← Back to News Overview


Busulfan currently has 0 news articles, with 20 predicted indications.

This page combines the AI-predicted indications for Busulfan with the latest health news. Indications highlighted in orange have recent news coverage.
Drug Information
  • Original indication: Busulfan Fresenius Kabi followed by cyclophosphamide (BuCy2) is indicated as conditioning treatment prior to conventional haematopoietic progenitor cell transplantation (HPCT) in adult patients when...
  • Evidence level: L5
  • Predicted indications (20):
    • myelodysplastic syndrome (99.6%)
    • refractory cytopenia of childhood (99.5%)
    • unclassified myelodysplastic syndrome (99.5%)
    • partial deletion of the long arm of chromosome 5 (99.5%)
    • aregenerative anemia (99.5%)
    • severe congenital hypochromic anemia with ringed sideroblasts (99.5%)
    • HIV infectious disease (99.4%)
    • neurodevelopmental disorder with ataxic gait, absent speech, and decreased cortical white matter (99.2%)
    • seborrheic keratosis (99.2%)
    • feline acquired immunodeficiency syndrome (99.1%)
    • simian immunodeficiency virus infection (99.1%)
    • rheumatoid arthritis (99.0%)
    • obsolete familial combined hyperlipidemia (99.0%)
    • female breast carcinoma (98.9%)
    • primary cutaneous T-cell lymphoma (98.8%)
    • vulvar inverted follicular keratosis (98.8%)
    • multiple sclerosis (98.7%)
    • granulomatous slack skin disease (98.6%)
    • seborrheic dermatitis (98.5%)
    • Crohn's colitis (98.4%)

View full drug report →

No related news yet. When news mentions this drug, it will be collected and shown here automatically.

Disclaimer: The news on this page is collected automatically and is for research reference only; it does not constitute medical advice.

Copyright © 2026 藥提醒科技有限公司 (yao.care). For research purposes only. Not medical advice.

This site uses Just the Docs, a documentation theme for Jekyll.